P4355Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/− heart failure in epirubicinum recipients for bladder cancer

Authors :: M.G. Man
Adrian Tase
G.E. Stanciulescu
I. Iorga-Siman
Gheorghe Săvoiu
Anca Tase
Source :: European Heart Journal. 38
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
Bladder cancer
Dysfunction heart
business.industry
Trimetazidine
Urology
Medicine
Cardiology and Cardiovascular Medicine
business
medicine.disease
medicine.drug

Full Text Access

Tools